Table 2. Participants’ demographic characteristics and psychopathological variables at the beginning of the study.
| Variable | Total (N = 307) | WCG (n = 152) | IG (n = 155) |
|---|---|---|---|
| Demographic characteristics | |||
| Gender (F/M/X)*1 | 216/88/3
(70.4/28.7/1.0%) |
98/51/3
(64.5/33.5/2.0%) |
118/37/0
(76.1/23.9/0%) |
| Age in years)*2 | 36.5 (9.5) | 36.6 (9.9) | 36.3 (9.2) |
| Educational level | |||
| University degree*1 | 151 (49.2%) | 71 (46.7%) | 80 (51.6%) |
| Upper secondary school qualification*1 | 101 (32.9%) | 52 (34.2%) | 49 (31.6%) |
| Intermediate secondary school qualification*1 | 48 (15.6%) | 24 (15.8%) | 24 (15.5%) |
| Lower secondary school qualification*1 | 7 (2.3%) | 5 (3.3%) | 2 (1.3%) |
| Psychopathology *2 | |||
| AAQoL (0–100)*2,*3 | 45.0 (8.7) | 44.6 (9.1) | 45.4 (8.3) |
| ASRS (dichot.: 0–18)*2,*3 | 14.7 (2.4) | 14.8 (2.3) | 14.5 (2.5) |
| CGI-S (1–7)*2,*3 | 5.4 (0.9) | 5.3 (0.9) | 5.4 (0.9) |
| PSS-4 (0–16)*2,*3,*4 | 6.9 (2.6) | 7.0 (2.9) | 6.7 (2.3) |
| PHQ-9 (0–27)*2,*3 | 13.1 (4.6) | 13.4 (4.5) | 12.9 (4.7) |
| GAD-7 (0–21)*2,*3 | 11.2 (4.3) | 11.2 (4.3) | 11.2 (4.2) |
| PHCS (8–40)*2,*3 | 24.4 (5.6) | 24.2 (5.7) | 23.6 (5.5) |
| Years since diagnosis)*2 | 2.8 (5.4) | 2.8 (4.5) | 2.9 (6.2) |
| ADHD medication | |||
| No use*1 | 94 (30.6%) | 54 (35.5%) | 40 (25.8%) |
| Regular use*1 | 213 (69.4%) | 98 (64.5%) | 115 (74.2%) |
| MARS-D (5–25)*2,*3,*5 | 20.7 (3.1) n = 213 | 20.1 (3.2) n = 98 | 21.2 (3.0) n = 115 |
*1
Expressed as n (%);
*2
expressed as mean (standard deviation);
*3
range in parentheses;
*4
lower scores = higher stress;
*5
only in patients with ADHD medication.
AAQoL, Adult ADHD Quality of Life; ASRS, Adult ADHD Self-Report Scale; CGI-S, Clinical Global Impression - Self-Report; dichot., dichotomous; GAD-7, Generalized Anxiety Disorder Scale 7; IG, intervention group; MARS-D, Medication Adherence Report Scale - German version; N, total sample size; n, sample size; PHCS, Perceived Health Competence Scale; PHQ-9, Patient Health Questionnaire 9; PSS-4, Perceived Stress Scale 4; WCG, waitlist control group